Dr. Karen Lin, MD

Dr. Lin practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Lin's NPI, 1194713099, was assigned on October 13, 2005. Dr. Lin graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 2001. Dr. Lin holds Pennsylvania license MD423353.

Dr. Lin's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Lin's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Lin is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Lin to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lin is licensed in Pennsylvania.

CMS data shows 309 Medicare services from Dr. Lin across 9 procedure codes in 2024, for 108 Medicare patients. Medicare paid $20,430 for them. Every service was in an office.

CMS counts 108 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 59, with 63% women.

In 2024, Dr. Lin wrote 2,169 Medicare Part D claims for 156 patients. 86% of them were for generic drugs. CMS names the drug for 1,727 of them, across 54 drugs with 11 or more claims each, at $160,108 in total drug cost. In 2023, CMS named 1,467 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 9 papers to Dr. Lin, published from 2013 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Anxiety, Depression and Stress Disorders, Post-Traumatic. Dr. Lin has published most often in J Psychosoc Nurs Ment Health Serv. Dr. Lin's most frequent co-authors are Ramin Parsey, MD, PhD and Irfan Rahman, MD.

Dmand AI links Dr. Lin to 1 clinical trial. Conditions studied include Diabetes, Gestational and Pregnancy Complications.

CMS Open Payments shows 1 general payment to Dr. Lin from 1 drug or device company in 2021. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $21.

Dr. Lin graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 2001.